Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 16:12:331-337.
doi: 10.1016/j.toxrep.2024.03.004. eCollection 2024 Jun.

Causes of acquired methemoglobinemia - A retrospective study at a large academic hospital

Affiliations

Causes of acquired methemoglobinemia - A retrospective study at a large academic hospital

Alex Belzer et al. Toxicol Rep. .

Abstract

Methemoglobinemia is a potentially life-threatening condition caused by the formation of methemoglobin, a form of hemoglobin that cannot bind oxygen. While there are some rare congenital causes of methemoglobinemia, most cases are acquired from the effects of specific drugs or environmental exposures. In this retrospective study, we analyzed a large data set of whole blood samples analyzed for methemoglobin at an academic medical center in Midwestern United States that provides both pediatric and adult services. For a 14 year timeframe (May 2009- June 2023), we performed detailed chart analysis of all patients with a methemoglobin concentration of 3.1 % or higher. For an earlier 13 year timeframe (January 1996-April 2009), we performed chart review for all patients with a methemoglobin concentration of 10.0 % or higher. For the 2009-2023 data, dapsone was the most frequent cause of methemoglobinemia (methemoglobin 3.1 % or higher) in both pediatric (73.3 %, 115 clinical encounters, 105 unique patients) and adult (65.3 %, 195 clinical encounters, 190 unique patients) populations. Inhaled nitric oxide as medical therapy was the next most frequent cause in both pediatric (18.1 %) and adult (13.2 %) populations. Causes associated with two or more unique episodes with methemoglobin concentrations of 10.0 % and higher included the following: dapsone (n = 40 episodes), benzocaine (n = 10), recreational use of amyl or isobutyl nitrite (n = 3), suicide attempt with sodium nitrite (n = 3 with 1 fatality; all 3 cases within last 3 years), food contaminated with nitrates (n = 2), and sepsis (n = 2). A total of 18 patients received treatment with methylene blue including 5 cases associated with benzocaine and all of the cases associated with amyl nitrite, isobutyl nitrite, sodium nitrite, and contaminated food. Only 3 patients with dapsone-associated methemoglobinemia received methylene blue, reflecting primary management by dose reduction or discontinuation of drug. Overall, our data reinforce previous studies showing dapsone, inhaled nitric oxide, and nitrites as common agents causing methemoglobinemia in a patient population seen at a medical center. Our data also are consistent with recent epidemiology trends showing increase in suicide attempts using sodium nitrite.

Keywords: Amyl nitrite; Cyanosis; Dapsone; Methemoglobinemia; Methylene blue; Nitrates; Nitric oxide; Sodium nitrite.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Distribution of methemoglobin concentrations in two retrospective time periods (January 1996 – April 2009 and May 2009 – June 2023). A. Data shown in linear scale. B. Data shown in logarithmic scale to better illustrate the elevated methemoglobin categories.

References

    1. Hall A.H., Kulig K.W., Rumack B.H. Drug- and chemical-induced methaemoglobinaemia. Clinical features and management. Med. Toxicol. 1986;1(4):253–260. - PubMed
    1. Rehman H.U. Methemoglobinemia. West. J. Med. 2001;175(3):193–196. - PMC - PubMed
    1. Sahu K.K., Mishra A. Methemoglobinemia: challenges in diagnosis and management. J. Assoc. Physicians India. 2019;67(8):94. - PubMed
    1. Coleman M.D., Coleman N.A. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf. 1996;14(6):394–405. - PubMed
    1. Darling R.C., Roughton F.J.W. The effect of methemoglobin on the equilibrium between oxygen and hemoglobin. Am. J. Physiol. 1942;137(1):56–68.

LinkOut - more resources